Boston Partners 7.85% Stake in Cross Country Healthcare

Cross Country Healthcare Inc reported a 7.85% beneficial holding of 2,538,481 shares by Boston Partners as of 03/31/2026.

Rhea-AI Filing Summary

Cross Country Healthcare Inc reported a 7.85% beneficial holding of 2,538,481 shares by Boston Partners as of 03/31/2026. The filing states these shares are held "for the discretionary account of certain clients," and Boston Partners reports sole voting and dispositive power over the shares.

Insights

Institutional Ownership Analyst

Boston Partners holds a material passive stake in CCRN as of 03/31/2026.

Boston Partners reports beneficial ownership of 2,538,481 shares, equal to 7.85% of the class, held in discretionary client accounts. The filing indicates sole voting and dispositive power.

This Schedule 13G is a disclosure of ownership; timing and any intent to trade are not specified in the excerpt. Subsequent filings could show changes in position.

Key Figures

Shares beneficially owned: 2,538,481 shares Percent of class: 7.85% CUSIP: 227483104 +1 more

4 metrics

Shares beneficially owned 2,538,481 shares reported as of 03/31/2026

Percent of class 7.85% percent of Common Stock as reported

CUSIP 227483104 identifier for Cross Country Healthcare common stock

Filing signature date 05/14/2026 Schedule 13G signature date

Key Terms

Schedule 13G, beneficial owner, discretionary account

3 terms

Schedule 13G regulatory

"This Schedule is being filed with respect to 2,538,481 shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficial owner regulatory

"By reason of rule 13d-3 under the act Boston Partners may be deemed to be a beneficial owner"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

discretionary account financial

"held by Boston Partners on 03/31/2026 for the discretionary account of certain clients"

An account in which the account holder gives a broker or advisor authority to buy and sell securities on their behalf without asking for permission for each trade. Like handing someone the keys to your car to run errands, it lets a professional act quickly and make ongoing decisions for you; this matters to investors because it changes who controls trade timing, affects fees and tax reporting, and shifts responsibility for execution and record-keeping.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Boston Partners report in CCRN?

Boston Partners reports beneficial ownership of 2,538,481 shares, or 7.85% of CCRN. The Schedule 13G lists the position as of 03/31/2026, with sole voting and dispositive power shown for Boston Partners.

Does Boston Partners control voting of the CCRN shares?

Yes — the filing shows sole voting power over 2,538,481 shares. The Schedule 13G also reports sole dispositive power, indicating Boston Partners can direct votes and dispositions for these shares.

Are the shares held for Boston Partners or clients?

The filing states the shares are held "for the discretionary account of certain clients." Boston Partners may be deemed the beneficial owner under Rule 13d-3 while managing those client accounts.

What is the reporting date for the 13G disclosure?

The ownership is reported as of 03/31/2026. The document is signed on 05/14/2026, which is the signature date for the Schedule 13G filing included in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 09:59 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

CROSS COUNTRY HEALTHCARE INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

227483104

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 227483104

1

Names of Reporting Persons

Boston Partners

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,538,481.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,538,481.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,538,481.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.85 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CROSS COUNTRY HEALTHCARE INC
(b)	Address of issuer's principal executive offices: 5201 CONGRESS AVENUE, SUITE 160, BOCA RATON, FLORIDA 33487
Item 2.
(a)	Name of person filing: Boston Partners
(b)	Address or principal business office or, if none, residence: ONE BEACON STREET 30TH FLOOR BOSTON, Massachusetts 02108
(c)	Citizenship: Boston Partners - DELAWARE
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 227483104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,538,481
(b)	Percent of class: 7.85 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Boston Partners - 2,538,481
	(ii) Shared power to vote or to direct the vote: Boston Partners - 0
	(iii) Sole power to dispose or to direct the disposition of: Boston Partners - 2,538,481
	(iv) Shared power to dispose or to direct the disposition of: Boston Partners - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. This Schedule is being filed with respect to 2,538,481 shares of CROSS COUNTRY HEALTHCARE INC. (the Common Stock) held by Boston Partners on 03/31/2026 for the discretionary account of certain clients. By reason of rule 13d-3 under the act Boston Partners may be deemed to be a beneficial owner of such Common Stock. To the knowledge of Boston Partners no person has the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of such Common Stock which represents more than 5% of the outstanding shares of the Common Stock referred to in item 4(b) hereof.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Boston Partners

Signature:	/s/ Ali Farooqi
Name/Title:	Ali Farooqi / Senior Compliance Manager
Date:	05/14/2026